Citation Impact
Citing Papers
Phase II Trial of Sorafenib in Advanced Thyroid Cancer
2008
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
2009 StandoutNobel
Sox11 Prevents Tumorigenesis of Glioma-Initiating Cells by Inducing Neuronal Differentiation
2009
MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma
2009
BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
2008
Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma
2008
Application of immunohistochemistry to thyroid neoplasms.
2008
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring
2013 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
microRNA-92a Promotes Lymph Node Metastasis of Human Esophageal Squamous Cell Carcinoma via E-Cadherin
2010
Transition from inflammation to proliferation: a critical step during wound healing
2016 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
B-Raf and the inhibitors: from bench to bedside
2013
Application of Immunohistochemistry to Thyroid Neoplasms
2008
Thyroid Nodules and Cancers in Children
2005
Favourable course of disease after incomplete remission on 131I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up
2010
Prognostic utility of BRAF mutation in papillary thyroid cancer
2009
Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAFV600E mutation, clinicopathological features, and immunohistochemical findings
2009
Regulation of microRNA function in animals
2018 Standout
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells
2011 StandoutNobel
Crossreactive B cells are present during a primary but not secondary response in BALB/c mice expressing a bcl-2 transgene
1999
The Differentiation of Benign and Malignant Thyroid Nodules
2005
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients
2011
Circular RNAs are a large class of animal RNAs with regulatory potency
2013 StandoutNature
Thyroid cancer
2016 Standout
Genetic effects on gene expression across human tissues
2017 StandoutNature
Utilization of Total Thyroidectomy for Differentiated Thyroid Cancer in Children
2010
Regulation of microRNA biogenesis
2014 Standout
A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer
2011
Association of BRAFV600EMutation with Poor Clinical Prognostic Factors and US Features in Korean Patients with Papillary Thyroid Microcarcinoma
2009
Papillary Microcarcinoma of the Thyroid: Clinical Characteristics and BRAFV600E Mutational Status of 977 Cases
2013
Upregulation of the Wnt/?-catenin Pathway Induced by Transforming Growth Factor-? in Hypertrophic Scars and Keloids
2006
Total Thyroidectomy and Adjuvant Radioiodine Treatment Independently Decrease Locoregional Recurrence Risk in Childhood and Adolescent Differentiated Thyroid Cancer
2007
The emerging role of lncRNAs in cancer
2015 Standout
The BRAF mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma
2006
The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer
2011
BRAF mutation in thyroid cancer
2005
Reduction of False-Negative Papillary Thyroid Carcinomas by the Routine Analysis of BRAFT1799A Mutation on Fine-Needle Aspiration Biopsy Specimens
2012
Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA)
2006
Current State and Future Perspective of Molecular Diagnosis of Fine-Needle Aspiration Biopsy of Thyroid Nodules
2011
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
2008
Research Article: Selectivity‐determining Residues in Plk1
2007
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
2011 Standout
Reoperative central compartment dissection for patients with recurrent/persistent papillary thyroid cancer: Efficacy, safety, and the association of the BRAF mutation
2012
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies
2010
BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment
2012
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
Are we really at the dawn of understanding sporadic pediatric thyroid carcinoma?
2015
The molecular biology of head and neck cancer
2010 Standout
Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer
2007
Complete Mitochondrial Genomes Reveal Neolithic Expansion into Europe
2012 StandoutNobel
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA
2011 Standout
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
2008 Standout
Control by a hair’s breadth: the role of microRNAs in the skin
2012
Pax-8–PPAR-γ fusion protein in thyroid carcinoma
2014
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules.
2006
The dark side of a tumor suppressor: anti-apoptotic p53
2008
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
2009
Anaplastic Thyroid Carcinoma, Thyroid Lymphoma, and Metastasis to Thyroid
2006
Natural RNA circles function as efficient microRNA sponges
2013 StandoutNature
The Chernobyl Thyroid Cancer Experience: Pathology
2011
Molecular Mechanisms of Long Noncoding RNAs
2011 Standout
BRAFV600E mutation and p27kip1 expression in papillary carcinomas of the thyroid ≤1 cm and their paired lymph node metastases
2007
Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns
2010
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
2011
Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level
2011
Cytomorphological and molecular genetic findings in pediatric thyroid fine‐needle aspiration
2012
Thyroid cancer in childhood: Management strategy, including dosimetry and long-term results
2007
Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hϋrthle cell thyroid lesions: results from a series of 505 consecutive patients
2006
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
The BRAF Mutation Is Predictive of Aggressive Clinicopathological Characteristics in Papillary Thyroid Microcarcinoma
2010
Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma
2011
New therapeutic advances in the management of progressive thyroid cancer
2009
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
miR-19 is a key oncogenic component of mir-17-92
2009
The Role of BRAFV600E Mutation and Ultrasonography for the Surgical Management of a Thyroid Nodule Suspicious for Papillary Thyroid Carcinoma on Cytology
2009
A single nucleotide polymorphism associated with isolated cleft lip and palate, thyroid cancer and hypothyroidism alters the activity of an oral epithelium and thyroid enhancer near FOXE1
2015
Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl
2011
Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
2010
Tackling the cancer stem cells — what challenges do they pose?
2014
MicroRNA-99 Family Targets AKT/mTOR Signaling Pathway in Dermal Wound Healing
2013
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Points of control in inflammation
2002 StandoutNature
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
2010 StandoutNature
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
2012 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
2002 StandoutNature
Molecular genetics and diagnosis of thyroid cancer
2011
Cancer-related inflammation
2008 StandoutNature
Radiation-induced thyroid cancer: What we have learned from Chernobyl
2006
Tenth Warren K. Sinclair Keynote Address—The Fukushima Nuclear Power Plant Accident and Comprehensive Health Risk Management
2013
TRIM family proteins and their emerging roles in innate immunity
2008
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study
2008
Intragenic Mutations in Thyroid Cancer
2008
I-131 Activities as High as Safely Administrable (AHASA) for the Treatment of Children and Adolescents with Advanced Differentiated Thyroid Cancer
2011
Conservative or radical surgery for pediatric papillary thyroid carcinoma: A systematic review of the literature
2015
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Outcomes of Surgically Managed Pediatric Thyroid Cancer
2009
Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto‐pathology diagnosis, especially in BRAFV600E mutation‐prevalent area
2006
A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells
2013
starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
2013 Standout
BRAF Mutations are Uncommon in Papillary Thyroid Cancer of Young Patients
2005
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
2012
Reflex BRAF Testing in Thyroid Fine-Needle Aspiration Biopsy with Equivocal and Positive Interpretation: A Prospective Study
2011
Clinical Behavior of Radiation-Induced Thyroid Cancer: Factors Related to Recurrence
2009
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
2011 Standout
The Golden Age of Transfer Hydrogenation
2015 Standout
A new mechanism of BRAF activation in human thyroid papillary carcinomas
2005
Side Population Cells Isolated from Mesenchymal Neoplasms Have Tumor Initiating Potential
2007
Surgical Results of Thyroid Nodules according to a Management Guideline Based on the BRAFV600E Mutation Status
2011
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
2006
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Long‐Term Outcome in 215 Children and Adolescents with Papillary Thyroid Cancer Treated During 1940 Through 2008
2010
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
2010 Standout
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation
2019 StandoutNobel
Artificial Metalloenzymes Based on the Biotin−Avidin Technology: Enantioselective Catalysis and Beyond
2010
Immune Complexes Present in the Sera of Autoimmune Mice Activate Rheumatoid Factor B Cells
2000
Pathogenesis, diagnosis and management of thyroid nodules in children
2006
Mice carrying a human GLUD2 gene recapitulate aspects of human transcriptome and metabolome development
2016 StandoutNobel
The role of microRNA genes in papillary thyroid carcinoma
2005 Standout
Initial Management and Follow-up of Differentiated Thyroid Cancer in Children
2010
MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells
2010
Conditional BRAFV600E Expression Induces DNA Synthesis, Apoptosis, Dedifferentiation, and Chromosomal Instability in Thyroid PCCL3 Cells
2005
Management of Low-Risk Differentiated Thyroid Cancer
2007
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Complement C4 Inhibits Systemic Autoimmunity through a Mechanism Independent of Complement Receptors Cr1 and Cr2
2000
High Rate of BRAF and RET/PTC Dual Mutations Associated with Recurrent Papillary Thyroid Carcinoma
2009
Approach to the Patient: Role of Dosimetric RAI Rx in Children With DTC
2013
Chemomimetic Biocatalysis: Exploiting the Synthetic Potential of Cofactor-Dependent Enzymes To Create New Catalysts
2015 StandoutNobel
BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications
2007
TheBRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study
2012
Twenty-Five Years After Chernobyl: Outcome of Radioiodine Treatment in Children and Adolescents With Very High-Risk Radiation-Induced Differentiated Thyroid Carcinoma
2013
Guidelines for the management of thyroid cancer
2014 Standout
BRAFV600E mutation and Its Association with Clinicopathological Features of Papillary Thyroid Cancer: A Meta-Analysis
2012
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
2005
The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy
2011
Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors
2007
Biological Role and Potential Therapeutic Targeting of the Chemokine Receptor CXCR4 in Undifferentiated Thyroid Cancer
2007
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Differentiated thyroid cancer in children and adults: same or distinct disease?
2007
BRAFV600E Mutation Analysis in Papillary Thyroid Carcinoma: Is it Useful for all Patients?
2013
Works of Vladimir Saenko being referenced
Novel tumorigenic rearrangement, Δrfp/ret, in a papillary thyroid carcinoma from externally irradiated patient
2003
The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population
2011
DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I collagen accumulation in keloid fibroblasts
2008
Oncogenic role of miR‐17‐92 cluster in anaplastic thyroid cancer cells
2008
Mechanisms of Disease: molecular genetics of childhood thyroid cancers
2007
BRAFV600EPromotes Invasiveness of Thyroid Cancer Cells through Nuclear Factor κB Activation
2006
Comprehensive Clinical Assessment of 740 Cases of Surgically Treated Thyroid Cancer in Children of Belarus
2006
The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl
2010
Radiation Exposure Does Not Significantly Contribute to the Risk of Recurrence of Chernobyl Thyroid Cancer
2010
The Selective Tyrosine Kinase Inhibitor, STI571, Inhibits Growth of Anaplastic Thyroid Cancer Cells
2003
Insulin-Like Growth Factor-I Enhances Transforming Growth Factor-β-Induced Extracellular Matrix Protein Production Through the P38/Activating Transcription Factor-2 Signaling Pathway in Keloid Fibroblasts
2003
Clinical Implication of Hot SpotBRAFMutation, V599E, in Papillary Thyroid Cancers
2003
Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF status
2006
Characterization of Side Population in Thyroid Cancer Cell Lines: Cancer Stem-Like Cells Are Enriched Partly But Not Exclusively
2007
Inhibition of Nuclear Factor-κB Cascade Potentiates the Effect of a Combination Treatment of Anaplastic Thyroid Cancer Cells
2004
RET oncogene amplification in thyroid cancer: correlations with radiation-associated and high-grade malignancy
2007
miR-196a Downregulation Increases the Expression of Type I and III Collagens in Keloid Fibroblasts
2012
Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant β‐catenin expression
2005
The Chernobyl Accident and its Consequences
2011
Radiation-Inducible hSNK Gene Is Transcriptionally Regulated by p53 Binding Homology Element in Human Thyroid Cells
2001
Cyclin D1 overexpression in thyroid tumours from a radio‐contaminated area and its correlation with Pin1 and aberrant β‐catenin expression
2004
Selective Pharmacologic Inhibition of c-Jun NH 2 -Terminal Kinase Radiosensitizes Thyroid Anaplastic Cancer Cell Lines via Induction of Terminal Growth Arrest
2006
The Usual Ultrasonographic Features of Thyroid Cancer Are Less Frequent in Small Tumors That Develop After a Long Latent Period After the Chernobyl Radiation Release Accident
2009
A Rapid and Simple Detection Method for the BRAF T1796A Mutation in Fine-Needle Aspirated Thyroid Carcinoma Cells
2004
Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present
2007
Molecular Mechanisms of the Effects of Low Concentrations of Taxol in Anaplastic Thyroid Cancer Cells
2004
Mutational and clinico-pathological analysis of papillary thyroid carcinoma in Serbia
2011
Childhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiation
2006
The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma
2004
Low Frequency of BRAFT1796A Mutations in Childhood Thyroid Carcinomas
2004
Large deletions in mitochondrial DNA in radiation-associated human thyroid tumors.
2002
Mitochondrial DNA and Human Thyroid Diseases
2004
TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer
2006
Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-κB Inhibitor, Enhances Antitumor Activity of Taxanes in Anaplastic Thyroid Cancer Cells
2008
Light Chain Usage in Anti–double-stranded DNA B Cell Subsets: Role in Cell Fate Determination
1997
Clinical Implications of Pre-Operative Rapid BRAF Analysis for Papillary Thyroid Cancer
2007
Molecular Analysis of Structural Abnormalities in Papillary Thyroid Carcinoma Genome
2004